Pelvic Examination

PROCEDURE3 trials

Sponsors

University of Miami, Boston Medical Center, Ohio State University Comprehensive Cancer Center

Conditions

Abdominal PainAnal CarcinomaCervical CancerCervical CarcinomaEarly Pregnancy BleedingEndometrial CarcinomaMalignant Pelvic NeoplasmRectal Carcinoma

Phase 1

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

CompletedNCT01485731

University of MiamiCervical Cancer

Start: 2012-01-31End: 2015-02-28Updated: 2015-06-03

Unknown Phase

Pelvic Examination in Pregnancy

CompletedNCT01570413

Boston Medical CenterAbdominal Pain, Early Pregnancy Bleeding

Start: 2012-02-29End: 2016-01-31Updated: 2017-05-04

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Active, not recruitingNCT04713618

Ohio State University Comprehensive Cancer CenterAnal Carcinoma, Cervical Carcinoma, Endometrial Carcinoma +4

Start: 2021-01-30End: 2026-12-31Target: 89Updated: 2025-03-18

Related Papers

Abstract 6529: Vaginal microbiome dynamics and clinical outcomes in cervical cancer patients undergoing radiotherapy

Cancer Research2026-04-03

Abstract 4693: Impact of pelvic radiation on vaginal microbiome and pelvic health: Findings from the GEORGIA Trial (NCT04713618)

Cancer Research2025-04-21

Phase I trial of nelfinavir added to cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.

Journal of Clinical Oncology2015-05-202 citations